News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Mexico And Singapore 5/22/2015
Highland Therapeutics Announces The Issuance Of Three U.S. Patents And One Notice Of Allowance 5/21/2015
I-MAK Release: Patent Challenges In Five Countries Dispute Validity Of Gilead (GILD)'s Claims To Hep C Drug Patents That Block Treatment For Up To 59 Million People 5/20/2015
Batu Biologics Files Patent On Blood Derived Anti-Cancer Immunomodulator 5/20/2015
Aphios Granted United States Patent For Alzheimer’s Disease Treatment 5/20/2015
Microlin Bio Announces Issuance Of Thirty Seven Additional Patents For The Use Of Microrna In Cancer Treatment And Diagnosis 5/19/2015
Hemostemix Receives Notice Of Allowance For Additional U.S. Patent On ACP-01 Covering Autologous Cell Therapy For Critical Limb Ischemia (CLI) 5/19/2015
New Patent Issued For Eagle Pharmaceuticals (EGRX)’ Bendamustine Rapid Infusion Product 5/19/2015
Auris Medical Holding AG Announces Notice Of Allowance From USPTO Related To Treating Middle Ear Diseases With Poloxamer-Based Fluoroquinolone Compositions 5/18/2015
Allegro Ophthalmics LLC Announces Issuance Of U.S. Patent For First-In-Class Integrin Peptide Therapy Candidate Luminate 5/18/2015
SanBio, Inc. Granted Key Patent In New Treatment For Chronic Stroke 5/15/2015
Hi-Tech Pharmaceutical Files Lawsuit Against The Third Most Litigious Patent Troll In America - Thermolife International And Ron Kramer - Sixty Six (66) Of Those Patents Were Licensed From Stanford University 5/14/2015
Suven Life Sciences Ltd Secures Two (2) Product Patents In Europe And Hong kong 5/13/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Methods Of Administration And Compositions In The Treatment Of Parkinson's Disease 5/13/2015
Nevro Announces Filing Of Petitions For Inter Partes Review Of U.S. Patent No. 8,359,102 5/12/2015
Relmada Therapeutics Announces Notice Of Allowance For U.S. Patent Covering SECUREL(TM), Its Abuse-Deterrent, Extended-Release, Technology Platform For Opioids 5/12/2015
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Sacituzumab Govitecan To 2033 5/12/2015
Hi-Tech Pharmacal (HITK) Files Lawsuit Against Patent Troll With Ties To Stanford University - Thermolife International And Ron Kramer Sued Over Racketeer Influenced And Corrupt Organization Act (RICO) And Deceptive Trade Practices 5/12/2015
Domainex Ltd Announces The Grant Of US And European Patents For Its Lead Programme, Targeting IKK Epsilon And TBK1 For The Treatment Of Diseases Such As COPD And Psoriasis 5/11/2015
Arno Therapeutics Receives USPTO Notice Of Allowance For Two Important Patents Covering Lead Compound Onapristone 5/7/2015
Mati Therapeutics Expands Patent Portfolio 5/7/2015
New England Biolabs, Inc. Release: US Patent Awarded For Industry-Leading RNA-Seq Technology 5/6/2015
GenSpera Enters National Phase With Patent Application For Injectable Prodrug Formulations 5/6/2015
Pluristem Life Systems Inc. Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow 5/6/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use For MANF 5/5/2015
Provectus Biopharmaceuticals Inc.'s Novel Synthesis Patent Application Allowed By European Patent Office, Patent Issued By Japan 5/5/2015
Mylan (MYL) Confirms First-To-File Patent Challenge Relating To Minivelle 5/5/2015
NuGene International, Inc. Files Additional Patent Applications 5/4/2015
Vaccine Improvement Patent Awarded To iBio, Inc. (IBIO) 5/4/2015
Everything You Wanted to Know About Biosimilars But Were Afraid to Ask: An Expert Interview -- Part 2 4/30/2015
Summit Therapeutics Granted Key Patent For Novel Antibiotic SMT19969 For The Treatment Of C. Difficile Infection 4/30/2015
Sensory Neurostimulation Announces Issuance Of U.S. Patent For Relaxis™, The First And Only FDA -Cleared Non-Drug Treatment To Improve Sleep For Patients With Restless Legs Syndrome 4/30/2015
Everything You Wanted to Know About Biosimilars But Were Afraid to Ask: An Expert Interview 4/30/2015
Iroko Pharmaceuticals Granted New Patent For ZORVOLEX 4/29/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/28/2015
GenSpera Granted New Patent For Prodrugs Activated By Prostate Specific Antigen 4/28/2015
Advaxis, Inc. Enhances Lm-LLO Cancer Immunotherapy Intellectual Property Portfolio With Two USPTO Patents Addressing ADXS-PSA And ADXS-HER2 4/28/2015
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug 'Stempeucel' 4/27/2015
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy 4/27/2015
Forward Pharma (FWP) Receives Decision To Grant From EPO For DMF Patent In Europe 4/27/2015
Molecular Health Gains Patent For Novel Receptor Utilizing Computational Biomarker Discovery Technology 4/27/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering Pennsaid 2% 4/27/2015
Suven Life Sciences Ltd Secures Five (5) Product Patents For Their Nces In Australia, Europe, Hong Kong, Israel And Norway 4/24/2015
US Patent Granted For Batu Biologics Cancer Immunotherapeutic Product Immxcyte 4/23/2015
Probiodrug AG Release: Key Patents On Glutaminyl Cyclase (QC) Inhibition For The Treatment Of Alzheimer’s Disease Granted In Japan 4/23/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance For U.S. Patent For Healing And Reversing Heart And Coronary Vessel Damage After A Heart Attack With TB4 4/23/2015
Marina Biotech, Inc. (MRNA) Expands Global Patent Protection Of Clinical Stage Nucleic Acid Delivery Technologies 4/23/2015
Edico Genome Issued Broad Patent For DRAGENTM From United States Patent And Trademark Office 4/23/2015
CDEX Inc. (CDEX) Granted New Patent For Chemical And Molecular Identification And Quantification System Utilizing Enhanced Photoemission Spectroscopy 4/23/2015
SteadyMed (STDY) Granted Additional U.S. Patent With Patent Term Extension 4/22/2015
Ariad (ARIA) Announces Issuance Of Key U.S. Patent On Brigatinib 4/22/2015
Clearside Biomedical Announces Purchase Of Iscience Patent Portfolio For Suprachoroidal Space Drug Delivery 4/22/2015
IntelGenx Corp. Is Awarded Patent From The United States Patent And Trademark Office (USPTO) 4/22/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS (Prednisone) Delayed-Release Tablets 4/22/2015
ERYtech Pharma Strengthens Its Intellectual Property Position In The U.S. 4/21/2015
Pfizer (PFE) And Provectus Biopharmaceuticals Inc. Receive Patent Allowance For Use Of PV-10 In Combination With Systemic Immunotherapy Agents In Treatment Of Cancer 4/20/2015
Emotional Brain Obtains Patent Extension For Its Female Sexual Dysfunction Medication 4/17/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID2% 4/17/2015
U.S. Patent Office Declares An Interference Between Forward Pharma (FWP) And Biogen (BIIB) Regarding The Treatment Of Multiple Sclerosis With 480 Mg Daily Dose Of DMF, The Active Ingredient In Tecfidera 4/16/2015
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015
Medac Pharma, Inc. Announces Settlement Of Patent Infringement Lawsuits 4/16/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For Additional U.S. Patent For RHB-105 H. Pylori Bacterial Infection Treatment 4/16/2015
Mylan (MYL) Settles Patent Litigation Related To Viagra 4/14/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Trial Date For Fanapt Patent Cases 4/14/2015
Compumedics Limited (CMP.AX) (ASX:CMP) DWL New Patent Granted Underpinning Growth Opportunities 4/14/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/14/2015
Karyopharm Therapeutics (KPTI) Granted U.S. Composition-Of-Matter Patent For Selinexor (KPT-330) 4/13/2015
Evoke Pharma, Inc. Granted European Union Formulation Patent For EVK-001 4/9/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of A New Fanapt Patent In The FDA Orange Book 4/9/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015
USPTO Issues Key US Patent To TiGenix For The Use Of Adipose-Derived Stromal Cells In The Treatment Of Fistulas 4/8/2015
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015
Arena Pharmaceuticals, Inc. (ARNA) Receives Additional Patent For BELVIQ (lorcaserin HCl) From United States Patent And Trademark Office 4/7/2015
Particle Sciences Receives Patent For Its Surface Arrayed Therapeutics Drug Delivery Platform 4/7/2015
Regen BioPharma Expands Its Differentiation Therapy of Cancer Stem Cells Platform With Filing Of Patent Applications On Silencing Of NR2F2 4/7/2015
Eagle Pharmaceuticals (EGRX) Announces New Patent For Low-Sodium Bendamustine 4/7/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Sixth U.S. Patent Protecting Trokendi XR 4/3/2015
Cleveland Biolabs Inc. (CBLI) Announces New U.S. Composition Of Matter Patent For CBLB612 4/2/2015
Meagan Medical Announces Issuance Of A Key U.S. Patent For A Disruptive Chronic Pain Treatment Using Spinal Cord Stimulation 4/1/2015
Kamada Ltd. (KMDA) Receives Allowance For Key Canadian Patent For Large Scale Production And Use Of Proprietary Alpha-1 Proteinase Inhibitor 4/1/2015
Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride 4/1/2015
AmpliPhi Biosciences Corporation (APHB) Granted European Patent For Bacteriophage Therapy To Fight Biofilm-related Bacterial Infections 3/31/2015
Adamas Pharmaceuticals (ADMS) Issued Patent 3/31/2015
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Acasti Pharma Granted Composition & Use Patent In China 3/25/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In India 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Highland Therapeutics Announces Receipt Of Two Notices Of Allowance For Patents On Lead Product 3/24/2015
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications 3/23/2015
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015
Onxeo Consolidates Its Intellectual Property With The Grant Of New Patent Protection Of Validive In Japan Until 2029 3/18/2015
Daxor Corporation (DXR) Receives Notification Of Patent Approval And Issues An Update On Its Stock Buyback Program 3/17/2015
InSite Vision (ISV) Announces Settlement Of Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) 3/17/2015
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015
Auris Medical AG (EARS) Announces Recently Granted Patent In India For The Treatment Of Tinnitus 3/13/2015
Enzymotec Granted New Patents In The United States And Australia Relevant To Phospholipid-Based Products 3/13/2015
Provectus Biopharmaceuticals Inc. Awarded PH-10 Patent By U.S. Patent And Trademark Office 3/12/2015
Federal Court Rules Millennium Health Infringes Patent Exclusively Licensed To Ameritox, Ltd. 3/12/2015
Flag Therapeutics Announces Bi-specific FTAC Patent Issuance 3/11/2015
Highland Therapeutics Announces Notice Of Patent Allowance; Provides Update On Amphetamine Development Plans 3/10/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015
Stevia Corp. Files Provisional Patent With The United States Patent And Trademark Office For A Non-Invasive And Simple To Use Delivery System For Cannabinoids 3/9/2015
Actavis (ACT) Confirms District Court Ruling In Atelvia Patent Litigation 3/5/2015
Islet Sciences Confirms Issuance Of U.S. Patent For Using SGLT2 Inhibitors To Treat NASH/NAFLD 3/5/2015
European Patent To Strengthen MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines Program 3/5/2015
Jaguar Animal Health Files Two Provisional Patent Applications, Deepening Its Pipeline Of Proprietary Gastrointestinal Products For Animals 3/4/2015
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent 3/3/2015
Regen BioPharma Files Patent Application For Treatment Of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy 3/3/2015
VG Life Sciences, Inc. (VGLS) Granted Key Composition Of Matter Patent 3/2/2015
Merus Labs International Inc. Announces Settlement Of Canadian Patent Litigation 3/2/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition 3/2/2015
DelMar Pharmaceuticals Receives Notice Of Allowance Of Fourth U.S. Patent Covering Methods Of Use And Compositions For VAL-083 3/2/2015
University of Maryland Release: Patent Awarded For Compounds That Inhibit Formation And Persistence Of Biofilms 3/2/2015
FLAG Therapeutics Announces The Issuance Of A New U.S. Patent That Includes Composition Of Matter On Their Bi-Specific Lead Candidate For Oncology 2/27/2015
Collegium Pharmaceutical, Inc. Announces Notice Of Allowance For U.S. Patent Covering Deterx, An Abuse-Deterrent, Extended-Release, Technology Platform 2/26/2015
Meditope Biosciences Announces Issuance Of Additional Patent For SnAP Technology 2/25/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage 2/25/2015
Ocata Therapeutics Receives Two New Patents For Immune-Modulatory Cell Technology 2/25/2015
Actavis (ACT) Confirms Generic Uceris Patent Challenge 2/25/2015
XstalBio: US Patent Issued For Stabilization Of Therapeutic Proteins 2/25/2015
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO Covering Cabaletta For The Treatment Of OPMD 2/24/2015
BeyondSpring Files Composition Of Matter Patent Application For Plinabulin Combination Therapy In Immuno-Oncology 2/24/2015
Ciclofilin Pharmaceuticals Granted Patent In Japan For Cyclophilin Inhibitor Drugs 2/24/2015
Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/23/2015
Opsona Therapeutics Ltd. Patent Issued In US And EU Covering The Opsona-Developed Antibody OPN-305, Which Is Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/20/2015
Aegis Therapeutics, LLC Awarded U.S. Patent No. 8,927,497 For Non-Invasive Delivery Of Anti-Seizure Drugs 2/18/2015
Synageva BioPharma (GEVA) European Patent Issued For Treatment Of LAL Deficiency 2/18/2015
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance In U.S. For Psoriasis Patent 2/17/2015
AdvaStim Expands Intellectual Property Portfolio With New Neurostimulation Patent 2/17/2015
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015
Rosetta Genomics Ltd. (ROSG) Announces Key Patent Allowances In U.S. And Europe 2/17/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 3rd US Patent 2/13/2015
Kinex Pharmaceuticals Licenses Patents From Hong Kong Polytechnic University 2/13/2015
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics 2/12/2015
New Reverdia Patents Strengthen Biosuccinium™ Licensing 2/12/2015
iBio, Inc. (IBIO) Receives U.S. And European Patents For Protein Expression Technology 2/12/2015
Hedge Fund Manager Picks Acorda Therapeutics (ACOR) as His First Victim Against the Pharmaceutical Industry and Its "BS" Patents 2/12/2015
AmnioLife Files Collagen Membrane Preservation Patent 2/11/2015
Novogen Limited (NVGN) Lodges Key Super-benzopyran Patent 2/11/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent Related To MOB-015 For The Treatment Of Onychomycosis 2/11/2015
Cleveland Biolabs Inc. (CBLI) Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents 2/11/2015
Cara Therapeutics, Inc. (CARA) Issued Additional U.S. Patent Covering The Expanded Use Of Kappa Opioid Receptor Agonist CR845 And Analogs For The Treatment And Prevention Of Pain-Related Conditions 2/10/2015
Drawbridge Pharmaceuticals Granted Notice Of Allowance For Divisional Patent In The United States 2/10/2015
Pivotal Therapeutics Inc. Announces The Issuance Of Two Patents Both Related To The Combination Of VASCAZEN® With Key Cholesterol Lowering Agents (Statins) And Cholesterol Absorption Inhibitors 2/10/2015
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015
MicroBiome Therapeutics LLC Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity 2/9/2015
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015
VBL Therapeutics (VBLX) Receives European Patent Issuance On Lecinoxoid Platform Technology 2/6/2015
Creative Medical Health Files Patent On Multiple Sclerosis Stem Cell Therapy 2/6/2015
NeuroNascent, Inc. Announces Expanded Patent Coverage In US And Russia For Its Alzheimer's Disease And Down Syndrome Therapeutics 2/5/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
ContraVir Pharmaceuticals' HBV Compound CMX157 Receives Extended Patent Life 2/4/2015
iBio, Inc. (IBIO) Adds To iBioModulator Portfolio And Product Pipeline 2/4/2015
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of NASH 2/4/2015
Aurinia (ISA.TO) Announces Recently Granted Nanomicellar Formulation Patents In Japan And China For Topical Ophthalmic Administration Of Voclosporin 2/4/2015
Oxis Biotech Inc. Provides Update For P62-ZZ Multiple Myeloma Patent Application 2/4/2015
ProLynx Issued Key Patent For Using Releasable Linkers On Insoluble Carriers 2/4/2015
ARCA biopharma Announces Patent Issuance For Methods And Compositions Of S-Isomer Formulation Of Gencaro 2/4/2015
Enzymotec Announces Favorable Response From The Australian Patent Office 2/3/2015
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Ocular Indications 2/3/2015
EastGate Biotech Provides Update On Its Patent Portfolio 2/3/2015
MMRGlobal Biotech Assets In Play As Company Is Awarded Second U.S. Cancer Fighting Patent 2/2/2015
MediciNova, Inc. Receives New Patent Covering MN-029 (denibulin) di-hydrochloride In Japan 1/30/2015
VG Life Sciences, Inc. (VGLS) Announces Issuance Of Patent Covering Treatment Of Inflammatory Bowel Disease With Clip-Inducing Agent 1/29/2015
Apricus Biosciences (APRI) Announces Issuance Of U.S. Patent For Rayva™ 1/28/2015
Adamis Pharmaceuticals (ADMP) Receives Notice Of Allowance For U.S. And Japanese Patents For Its Dry Powder Inhaler 1/28/2015
Garnet Biotherapeutics, Inc. Files Amicus Brief To Support Its Victory Against Athersys, Inc. (ATHX) In Patent Interference 1/28/2015
BioTime (BTX) Announces Issuance Of 14 New Patents In The Fields Of Regenerative Medicine, Stem Cell Technology, And Cancer Therapy 1/26/2015
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015
KannaLife Sciences, Inc. Files PCT Patent Application For Novel Treatments for Neurodegenerative Disorders 1/23/2015
European Patent Office Issues Key Patent To TiGenix For Expanded Adipose-Derived Stem Cell Compositions 1/22/2015
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015
Ablynx (ABLYF) Successfully Opposes Patent Appeal Case By Domantis Limited (GlaxoSmithKline (GSK)) 1/22/2015
Fuisz Pharma Announces New Patent Allowance For Its Helicopter™ Tablet Shape With Improved Swallowability; Adds To Existing Tablet Shape Patent Estate 1/20/2015
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015
Akorn, Inc. (AKN) Confirms Generic Durezol® Patent Challenge 1/16/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing of a New Fanapt® Patent In The FDA Orange Book 1/16/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Israel For Oral Administration Of GLP-1 1/16/2015
Spotlight Innovation Subsidiary Celtic Biotech Iowa Granted Patent By The U.S. Patent And Trademark Office 1/16/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
DelMar Pharmaceuticals Receives Notice Of Allowance For Third US Patent For VAL-083 1/13/2015
NanoSphere Health Sciences Announces Patent-Pending Status For Nanoparticle Encapsulation Of NSAIDs 1/13/2015
OncoSec Medical Inc. Obtains Allowance Of Key Patent Application For Intratumoral Delivery Of Plasmid IL-15 1/13/2015
BioD Receives U.S. Patent For Unique Placental Tissue Technology 1/12/2015
Aradigm Corporation (ARDM) Granted Key Composition Of Matter Patents For Pulmaquin In Europe And Australia 1/12/2015
Silver Bullet Therapeutics Announces Issuance Of U.S. Patent No. 8,927,004 For Bioabsorbable Substrates That Controllably Release Metal Ions 1/12/2015
Chimerix, Inc. (CMRX) Receives Notice Of Allowance For Brincidofovir Composition Of Matter Patent Extending Exclusivity To 2034 1/12/2015
Altos Therapeutics Receives Second Issued Patent Covering Novel Dopamine D2/D3 Antagonists For The Treatment Of Gastrointestinal Diseases 1/12/2015



//-->